5QY-19320-21223
4 vaccinations
2 coded responses
44 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 040 / ME
- Registered
- 2021-06-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
8HG-20007-85300
Child or adolescent in my care · Female · 2022-06-21
Timeline
-
2021-06-14
Dose 1 — Pfizer-BioNTech
-
2021-06-15
Registered in v-safe
-
2021-06-15
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-06-16
- 2021-06-17
- 2021-06-18
- 2021-06-19
- 2021-06-20
- 2021-06-21
- 2021-06-28
- 2021-07-05
-
2021-07-06
Dose 2 — Pfizer-BioNTech
- 2021-07-06
-
2021-07-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-07-08
- 2021-07-09
- 2021-07-10
- 2021-07-12
- 2021-07-13
- 2021-07-20
- 2021-07-27
- 2021-08-03
- 2021-08-10
- 2021-08-17
- 2021-10-05
- 2022-01-04
-
2022-01-06
Dose 3 — Pfizer-BioNTech
- 2022-01-07
- 2022-01-08
- 2022-01-09
- 2022-01-10
- 2022-01-11
- 2022-01-13
- 2022-01-20
- 2022-01-27
- 2022-02-03
-
2022-02-10
Survey response — day 35, dose 3MedDRA: Nasal congestion, Oropharyngeal pain — Feeling: FairFree text: Nose congested, sore throatMedDRA releases: 2024-11 · check-in free text available
- 2022-02-17
- 2022-04-07
-
2022-07-07
Survey response — 6 months, dose 3MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Covid +MedDRA releases: 2024-11 · check-in free text available
-
2022-09-13
Dose 4 — Pfizer-BioNTech
- 2022-09-14
- 2022-09-20
- 2022-09-27
- 2022-10-13
- 2022-10-18
- 2022-10-25
- 2022-12-13
- 2023-03-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-14 | Pfizer-BioNTech | |
| 2 | 2021-07-06 | Pfizer-BioNTech | No |
| 3 | 2022-01-06 | Pfizer-BioNTech | No |
| 4 | 2022-09-13 | Pfizer-BioNTech | No |
Free text
Release 11 — day 35, dose 3
Symptoms: Nose congested, sore throat
Release 12 — 6 months, dose 3
Symptoms: Covid +
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release